Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Intrapartum Antibiotic Prophylaxis to Prevent Group B Streptococcal Early-onset Disease on Maternal Vaginal Microbiome, Intestinal Microbiome and Immunity of Offspring

NCT05738473 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT05738473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05738473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Intrapartum Antibiotic Prophylaxis to Prevent Group B Streptococcal Early-onset Disease on Maternal Vaginal Microbiome, Intestinal Microbiome and Immunity of Offspring
Lead sponsor
Zhujiang Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 23, 2022
Completion date
June 30, 2023
Enrollment
492 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microbiome, human